Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1876

1.

One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.

Natsuaki M, Morimoto T, Yamamoto E, Watanabe H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Hanaoka KI, Tanabe K, Kozuma K, Kimura T; STOPDAPT trial investigators.

PLoS One. 2020 Mar 25;15(3):e0227612. doi: 10.1371/journal.pone.0227612. eCollection 2020.

2.

Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.

Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Watanabe H, Yamaji K, Watanabe H, Kato T, Saito N, Ando K, Kadota K, Furukawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ J. 2020 Mar 17. doi: 10.1253/circj.CJ-19-1117. [Epub ahead of print]

3.

Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study.

Izumi C, Miyake M, Amano M, Kitai T, Obayashi Y, Takegami M, Kimura T, Sugio K, Matsumoto T, Nishimura K, Furukawa Y.

J Cardiol. 2020 Mar 7. pii: S0914-5087(20)30062-9. doi: 10.1016/j.jjcc.2020.02.006. [Epub ahead of print]

4.

Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men.

Yamasaki N, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Sato M, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Sato H, Kawamori R, Watada H.

Sci Rep. 2020 Mar 5;10(1):4102. doi: 10.1038/s41598-020-61080-5.

5.

Citrus Auraptene Induces Expression of Brain-Derived Neurotrophic Factor in Neuro2a Cells.

Furukawa Y, Washimi YS, Hara RI, Yamaoka M, Okuyama S, Sawamoto A, Nakajima M.

Molecules. 2020 Mar 3;25(5). pii: E1117. doi: 10.3390/molecules25051117.

6.

Characteristics associated with elevated 1-h plasma glucose levels during a 75-g oral glucose tolerance test in non-obese Japanese men.

Sato M, Tamura Y, Someya Y, Takeno K, Kaga H, Kadowaki S, Sugimoto D, Kakehi S, Funayama T, Furukawa Y, Suzuki R, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Sato H, Kawamori R, Watada H.

J Diabetes Investig. 2020 Mar 4. doi: 10.1111/jdi.13245. [Epub ahead of print]

7.

Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure.

Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T.

Sci Rep. 2020 Feb 24;10(1):3320. doi: 10.1038/s41598-020-60404-9.

8.

Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).

Seo M, Yamada T, Tamaki S, Watanabe T, Morita T, Furukawa Y, Kawasaki M, Kikuchi A, Kawai T, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Kimura T, Ueda K, Sakamoto D, Sakata Y, Fukunami M.

Eur Heart J Cardiovasc Imaging. 2020 Feb 24. pii: jeaa025. doi: 10.1093/ehjci/jeaa025. [Epub ahead of print]

PMID:
32091079
9.

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.

Kurimoto C, Inaba H, Ariyasu H, Iwakura H, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Morita S, Yamamoto Y, Yamashita S, Katsuda M, Hayata A, Akamatsu H, Jinnin M, Hara I, Yamaue H, Akamizu T.

Cancer Sci. 2020 Feb 22. doi: 10.1111/cas.14363. [Epub ahead of print]

10.

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators.

Cardiovasc Interv Ther. 2020 Feb 21. doi: 10.1007/s12928-020-00651-9. [Epub ahead of print]

PMID:
32086787
11.

Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study.

Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Kato M, Ikeda T, Furukawa Y, Nakagawa Y, Sato Y, Kuwahara K, Kimura T.

BMJ Open. 2020 Feb 16;10(2):e032674. doi: 10.1136/bmjopen-2019-032674.

12.

Molecular basis of clonal evolution in multiple myeloma.

Furukawa Y, Kikuchi J.

Int J Hematol. 2020 Apr;111(4):496-511. doi: 10.1007/s12185-020-02829-6. Epub 2020 Feb 6. Review.

PMID:
32026210
13.

Shape of the glucose response curve during an oral glucose tolerance test is associated with insulin clearance and muscle insulin sensitivity in healthy non-obese men.

Kaga H, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Suzuki R, Sugimoto D, Kadowaki S, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Giacca A, Sato H, Kawamori R, Watada H.

J Diabetes Investig. 2020 Feb 5. doi: 10.1111/jdi.13227. [Epub ahead of print]

14.

Cough peak flow with different mechanically assisted coughing approaches under different conditions in patients with neuromuscular disorders.

Kikuchi K, Satake M, Terui Y, Kimoto Y, Iwasawa S, Furukawa Y.

Phys Ther Res. 2019 Jun 7;22(2):58-65. doi: 10.1298/ptr.E9978. eCollection 2019.

15.

Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1.

Kai H, Katoh A, Harada H, Niiyama H, Furukawa Y, Kimura T; CREDO-Kyoto Investigators.

Hypertens Res. 2020 Feb 4. doi: 10.1038/s41440-020-0407-3. [Epub ahead of print]

PMID:
32015482
16.

Clinical Features of Spontaneous Isolated Dissection of Abdominal Visceral Arteries.

Shiraki H, Kasamoto M, Yasutomi M, Kaji S, Akutsu K, Furukawa Y, Shimizu W, Inoue N.

J Clin Med Res. 2020 Jan;12(1):13-17. doi: 10.14740/jocmr3916. Epub 2020 Jan 6.

17.

Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients.

Yamamoto S, Koyama D, Igarashi R, Maki T, Mizuno H, Furukawa Y, Kuro-O M.

Intern Med. 2020;59(3):345-355. doi: 10.2169/internalmedicine.3597-19. Epub 2020 Feb 1.

18.

Sex-related differences in the response to exercise testing in asymptomatic aortic stenosis.

Kim K, Furukawa Y.

Int J Cardiol. 2020 Apr 1;304:128-129. doi: 10.1016/j.ijcard.2020.01.050. Epub 2020 Jan 22. No abstract available.

PMID:
32007228
19.

Sox2 gene regulation via the D1 enhancer in embryonic neural tube and neural crest by the combined action of SOX2 and ZIC2.

Iida H, Furukawa Y, Teramoto M, Suzuki H, Takemoto T, Uchikawa M, Kondoh H.

Genes Cells. 2020 Jan 29. doi: 10.1111/gtc.12753. [Epub ahead of print]

PMID:
31997540
20.

Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.

Takeji Y, Shiomi H, Morimoto T, Furukawa Y, Ehara N, Nakagawa Y, Kato T, Tazaki J, Kato ET, Yaku H, Yoshikawa Y, Tada T, Hanyu M, Kadota K, Komiya T, Ando K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort Investigators.

Circ J. 2020 Feb 25;84(3):471-478. doi: 10.1253/circj.CJ-19-0980. Epub 2020 Jan 29.

21.

Mirtazapine-induced long QT syndrome in an elderly patient: a case report.

Matsuda Y, Furukawa Y, Yamazaki R, Inamura K, Kito S, Nunomura A, Shigeta M.

Psychogeriatrics. 2020 Jan 23. doi: 10.1111/psyg.12520. [Epub ahead of print] No abstract available.

PMID:
31975466
22.

Challenge for the in silico translation of Na channel blockade effects on human-ECG parameters.

Yoshinaga T, Kubo T, Asakura K, Abe Y, Saitou R, Shirakawa T, Furukawa Y, Ashihara T.

J Pharmacol Toxicol Methods. 2019 Sep - Oct;99:106595. doi: 10.1016/j.vascn.2019.05.112. Epub 2019 Oct 17. No abstract available.

PMID:
31962994
23.

Successful Planned Pregnancy through Vitrified-Warmed Embryo Transfer in a Woman with Chronic Myeloid Leukemia: Case Report and Literature Review.

Furukawa Y, Takahashi T, Suganuma R, Ohara M, Ota K, Kyozuka H, Yamaguchi A, Soeda S, Watanabe T, Komiya H, Mizunuma H, Fujimori K.

Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020005. doi: 10.4084/MJHID.2020.005. eCollection 2020.

24.

Diagnostic accuracy of specific IgG antibodies for bird fancier's lung: a systematic review and meta-analysis.

Shiroshita A, Tanaka Y, Nakashima K, Furukawa Y, Kataoka Y.

Ann Transl Med. 2019 Nov;7(22):655. doi: 10.21037/atm.2019.10.65.

25.

Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure.

Kitai T, Xanthopoulos A, Tang WHW, Kaji S, Furukawa Y, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Skoularigis J, Triposkiadis F, Matsue Y.

Int J Cardiol. 2019 Dec 28. pii: S0167-5273(19)35400-2. doi: 10.1016/j.ijcard.2019.12.051. [Epub ahead of print]

PMID:
31926640
26.

Nicotinic acetylcholine receptor signaling regulates inositol-requiring enzyme 1α activation to protect β-cells against terminal unfolded protein response under irremediable endoplasmic reticulum stress.

Ishibashi T, Morita S, Kishimoto S, Uraki S, Takeshima K, Furukawa Y, Inaba H, Ariyasu H, Iwakura H, Furuta H, Nishi M, Papa FR, Akamizu T.

J Diabetes Investig. 2020 Jan 10. doi: 10.1111/jdi.13211. [Epub ahead of print]

27.

Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.

Yamaguchi K, Nagatoishi S, Tsumoto K, Furukawa Y.

Cancer Sci. 2020 Mar;111(3):783-794. doi: 10.1111/cas.14297. Epub 2020 Feb 5. Review.

28.

Citrus Auraptene Induces Glial Cell Line-Derived Neurotrophic Factor in C6 Cells.

Furukawa Y, Hara RI, Nakaya M, Okuyama S, Sawamoto A, Nakajima M.

Int J Mol Sci. 2019 Dec 30;21(1). pii: E253. doi: 10.3390/ijms21010253.

29.

Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation.

Anzai I, Tokuda E, Handa S, Misawa H, Akiyama S, Furukawa Y.

Free Radic Biol Med. 2020 Feb 1;147:187-199. doi: 10.1016/j.freeradbiomed.2019.12.017. Epub 2019 Dec 19.

PMID:
31863908
30.

Risk Factors for Major Bleeding and Clinically Relevant Non-major Bleeding in Japanese Patients Treated with Edoxaban.

Takase T, Ikesue H, Nakagawa H, Kinoshita M, Muroi N, Kitai T, Furukawa Y, Hashida T.

Biol Pharm Bull. 2020 Mar 1;43(3):458-462. doi: 10.1248/bpb.b19-00799. Epub 2019 Dec 18.

31.

T-cell activation-inhibitory assay: a proposed novel method for screening caloric restriction mimetics.

Iura S, Ojima Y, Amakura Y, Yoshimura M, Sawamoto A, Okuyama S, Furukawa Y, Nakajima M.

Biomed Res. 2019;40(6):235-241. doi: 10.2220/biomedres.40.235.

32.

[A case of liver metastasis 11 years after resection of a gastrointestinal stromal tumor of the duodenum].

Kishi Y, Takaki S, Fukuhara T, Mori N, Okanobu H, Tsuji K, Maeda T, Fujiwara M, Nagai K, Furukawa Y.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(12):1030-1038. doi: 10.11405/nisshoshi.116.1030. Japanese.

PMID:
31827043
33.

Are cardiac sympathetic nerve activity and epicardial adipose tissue associated with atrial fibrillation recurrence after catheter ablation in patients without heart failure?

Kawasaki M, Yamada T, Furukawa Y, Morita T, Tamaki S, Kida H, Sakata Y, Fukunami M.

Int J Cardiol. 2020 Mar 15;303:41-48. doi: 10.1016/j.ijcard.2019.11.092. Epub 2019 Nov 9.

PMID:
31810812
34.

Genetic Creutzfeldt-Jakob disease mimicking dementia with Lewy bodies: Clinical and radiological findings.

Tomizawa Y, Taniguchi D, Furukawa Y.

J Neurol Sci. 2020 Feb 15;409:116604. doi: 10.1016/j.jns.2019.116604. Epub 2019 Nov 28. No abstract available.

PMID:
31805431
35.

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.

Tokuda E, Takei YI, Ohara S, Fujiwara N, Hozumi I, Furukawa Y.

Mol Neurodegener. 2019 Nov 19;14(1):42. doi: 10.1186/s13024-019-0341-5.

36.

Extraterrestrial ribose and other sugars in primitive meteorites.

Furukawa Y, Chikaraishi Y, Ohkouchi N, Ogawa NO, Glavin DP, Dworkin JP, Abe C, Nakamura T.

Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24440-24445. doi: 10.1073/pnas.1907169116. Epub 2019 Nov 18.

37.

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.

Natsuaki M, Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, Kato T, Ando K, Nakagawa Y, Furukawa Y, Tada T, Nagao K, Kadota K, Toyofuku M, Kimura T.

Circ Cardiovasc Interv. 2019 Nov;12(11):e008307. doi: 10.1161/CIRCINTERVENTIONS.119.008307. Epub 2019 Nov 11.

PMID:
31707804
38.

Tasuki for neck pain: An individually-randomized, open-label, waiting-list-controlled trial.

Furukawa Y.

J Occup Health. 2019 Nov 8. doi: 10.1002/1348-9585.12097. [Epub ahead of print]

39.

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.

Natsuaki M, Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG registry cohort‐2, RESET and NEXT trial investigators.

J Am Heart Assoc. 2019 Nov 19;8(22):e013356. doi: 10.1161/JAHA.119.013356. Epub 2019 Nov 8.

40.

Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.

Nagao K, Watanabe H, Morimoto T, Inada T, Hayashi F, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Natsuaki M, Kozuma K, Tanabe K, Morino Y, Shiomi H, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort‐2, RESET, and NEXT Investigators.

J Am Heart Assoc. 2019 Nov 19;8(22):e013703. doi: 10.1161/JAHA.119.013703. Epub 2019 Nov 8.

41.

Kinetics of cytokine receptor internalization under steady-state conditions affects growth of neighboring blood cells.

Nagamachi A, Kikuchi J, Kanai A, Furukawa Y, Inaba T.

Haematologica. 2019 Oct 31. pii: haematol.2019.232959. doi: 10.3324/haematol.2019.232959. [Epub ahead of print]

42.

Heptamethoxyflavone inhibits adipogenesis via enhancing PKA signaling.

Sawamoto A, Nakanishi M, Okuyama S, Furukawa Y, Nakajima M.

Eur J Pharmacol. 2019 Dec 15;865:172758. doi: 10.1016/j.ejphar.2019.172758. Epub 2019 Oct 28.

PMID:
31672599
43.

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.

Takase T, Ikesue H, Nakagawa H, Kinoshita M, Muroi N, Kitai T, Furukawa Y, Hashida T.

J Clin Pharm Ther. 2020 Apr;45(2):298-302. doi: 10.1111/jcpt.13065. Epub 2019 Oct 11.

44.

Association of oral health status with the CD4+ cell count in children living with HIV in Phnom Penh, Cambodia.

Kikuchi K, Furukawa Y, Tuot S, Pal K, Huot C, Yi S.

Sci Rep. 2019 Oct 10;9(1):14610. doi: 10.1038/s41598-019-51077-0.

45.

Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients.

Ikenoue T, Arai M, Ishioka C, Iwama T, Kaneko S, Matsubara N, Moriya Y, Nomizu T, Sugano K, Tamura K, Tomita N, Yoshida T, Sugihara K, Naruse H, Yamaguchi K, Nojima M, Nakamura Y, Furukawa Y; Japanese society for cancer of the colon and rectum (JSCCR).

J Hum Genet. 2019 Dec;64(12):1187-1194. doi: 10.1038/s10038-019-0674-5. Epub 2019 Oct 7.

PMID:
31588121
46.

Identification of the characteristic components in walnut and anti-inflammatory effect of glansreginin A as an indicator for quality evaluation.

Haramiishi R, Okuyama S, Yoshimura M, Nakajima M, Furukawa Y, Ito H, Amakura Y.

Biosci Biotechnol Biochem. 2020 Jan;84(1):187-197. doi: 10.1080/09168451.2019.1670046. Epub 2019 Sep 28.

PMID:
31566092
47.

[Corticospinal Tract Mapping by Calculating the Ratio of Subcortical to Cortical Stimulation Intensity:A Technical Note].

Hiruta R, Fujii M, Furukawa Y, Ichikawa T, Suzuki K, Watanabe Y, Nemoto M, Sato T, Sakuma J, Saito K.

No Shinkei Geka. 2019 Sep;47(9):957-960. doi: 10.11477/mf.1436204054. Japanese.

PMID:
31564656
48.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators.

Circulation. 2019 Dec 3;140(23):1957-1959. doi: 10.1161/CIRCULATIONAHA.119.043613. Epub 2019 Sep 27. No abstract available.

PMID:
31560216
49.

Higher C-Peptide Level During Glucose Clamp Is Associated With Muscle Insulin Resistance in Nonobese Japanese Men.

Kaga H, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Suzuki R, Sugimoto D, Kadowaki S, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Giacca A, Kanazawa A, Kawamori R, Watada H.

J Endocr Soc. 2019 Jul 23;3(10):1847-1857. doi: 10.1210/js.2019-00167. eCollection 2019 Oct 1.

50.

Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis.

Furukawa Y, Hamada H, Kamikawaji K, Unoki T, Inoue H, Tashiro Y, Okamoto M, Baba M, Hashiguchi T.

J Infect Chemother. 2020 Feb;26(2):279-281. doi: 10.1016/j.jiac.2019.08.012. Epub 2019 Sep 19.

PMID:
31543435

Supplemental Content

Loading ...
Support Center